Pulmatrix (PULM) Short term Debt (2014 - 2018)
Pulmatrix (PULM) posted Short term Debt of $2.5 million for Q1 2018, down 21.64% sequentially from $3.2 million in Q4 2017, and down 5.15% YoY from $2.7 million in Q1 2017.
Pulmatrix (PULM) Short term Debt (2014 - 2018) Analysis & Trends
Pulmatrix has reported Short term Debt for 5 years, with the latest figure at $2.5 million in Q1 2018.
- Quarterly Short term Debt fell 5.15% year-over-year to $2.5 million in Q1 2018, while the trailing twelve-month figure through Mar 2018 was $2.5 million (down 5.15% YoY) and the FY2017 annual result came in at $3.2 million, up 24.56% from the prior year.
- Short term Debt retreated to $2.5 million in Q1 2018 per PULM's latest filing, from $3.2 million in the prior quarter.
- Over five years, Short term Debt peaked at $3.9 million in Q3 2017 and troughed at $1000.0 in Q4 2014.
- A 5-year average of $1.7 million and a median of $2.2 million in 2016 frame the typical range for Short term Debt.
- The sharpest annual moves came in 2015 and 2018: Short term Debt soared 102800.0% in 2015, then declined 5.15% in 2018.
- Over 5 years, Short term Debt stood at $1000.0 in 2014, then jumped by 102800.0% to $1.0 million in 2015, then soared by 151.31% to $2.6 million in 2016, then increased by 24.56% to $3.2 million in 2017, then retreated by 21.64% to $2.5 million in 2018.
- According to Business Quant data, Short term Debt over the past three periods registered $2.5 million, $3.2 million, and $3.9 million for Q1 2018, Q4 2017, and Q3 2017 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.25 Bn | 131.40 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.03 Bn | 9.63 Bn | 668.28 Mn |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Pulmatrix | 5.55 Mn | 5.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 2.52 Mn |
| Dec 31, 2017 | 3.22 Mn |
| Sep 30, 2017 | 3.90 Mn |
| Jun 30, 2017 | 2.75 Mn |
| Mar 31, 2017 | 2.66 Mn |
| Dec 31, 2016 | 2.59 Mn |
| Sep 30, 2016 | 2.51 Mn |
| Jun 30, 2016 | 2.23 Mn |
| Mar 31, 2016 | 1.68 Mn |
| Dec 31, 2015 | 1.03 Mn |
| Sep 30, 2015 | 413,000.00 |
| Dec 31, 2014 | 1,000.00 |
| Sep 30, 2014 | 2,000.00 |
| Jun 30, 2014 | 7,000.00 |
| Mar 31, 2014 | 537,000.00 |